CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-10 | SELICK HAROLD E Director | Option exercise · Stock Option (right to buy) | −6,196 | 0 | ||
| 2023-02-22 | PATEL DINESH V PH D President and CEO | Gift | −10,000 | 583,448 | ||
| 2023-01-16 | Giraudo Bryan Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-01-16 | Williams Lewis T Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-01-16 | Waddill William D. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-01-16 | Noonberg Sarah B. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-01-16 | O'Dowd Sarah A Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-01-16 | SELICK HAROLD E Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-01-16 | Gupta Suneel Chief Development Officer | Grant or award | +20,625 | 138,187 | ||
| 2023-01-16 | Gupta Suneel Chief Development Officer | Grant or award · Stock Option (right to buy) | +123,750 | 123,750 | ||
| 2023-01-16 | Ali Asif Chief Financial Officer | Grant or award | +10,625 | 24,375 | ||
| 2023-01-16 | Ali Asif Chief Financial Officer | Grant or award · Stock Option (right to buy) | +63,750 | 63,750 | ||
| 2023-01-16 | MOLINA ARTURO MD Chief Medical Officer | Grant or award | +3,125 | 24,375 | ||
| 2023-01-16 | MOLINA ARTURO MD Chief Medical Officer | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2023-01-16 | PATEL DINESH V PH D President and CEO | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2022-12-28 | PATEL DINESH V PH D President and CEO | Gift | −3,116 | 598,096 | ||
| 2022-11-16 | Liu David Y Chief R&D Strategy Officer | Option exercise | +13,767 | $0.87 | $12K | 80,878 |
| 2022-11-16 | Liu David Y Chief R&D Strategy Officer | Option exercise | +9,726 | $1.89 | $18K | 90,604 |
| 2022-11-16 | Liu David Y Chief R&D Strategy Officer | Option exercise | +5,999 | $1.89 | $11K | 96,603 |
| 2022-11-16 | Liu David Y Chief R&D Strategy Officer | Option exercise | +35,656 | $1.16 | $41K | 132,259 |
Page 15 of 29 · 580 trades